Sedation exists on a continuum from minimal anxiolysis through to general anaesthesia. The key nursing distinction is moderate (conscious) sedation — the target level for most procedural sedation outside the operating theatre.
Sedation can deepen unexpectedly. A patient intended for moderate sedation can drift into deep sedation or general anaesthesia. Always be prepared to manage one level deeper than intended.
In GCC, the term "moderate sedation" is preferred in hospital policy. Nurses administer under physician/anaesthetic oversight per DHA/DOH/SCFHS/QCHP scope of practice frameworks.
Deep sedation crosses into an arena requiring airway management skills. It is used in:
Scope of Practice (GCC): Nurses must NOT independently target deep sedation. If a patient reaches deep sedation during moderate sedation, call for anaesthetic/senior support immediately.
The RASS is the standard bedside tool for assessing and targeting sedation depth in procedural and ICU settings across GCC facilities. Target for procedural sedation: RASS 0 to -2.
Procedural sedation target: RASS 0 to -2. RASS -3 and below = deep sedation territory — escalate, do not continue titrating independently.
Target for most ICU sedation: Ramsay 2–3. Target for procedural sedation: Ramsay 2–3 (awake but tranquil). Used less commonly now but still appears in GCC exam questions.
GCC scope: Most facility sedation policies allow nurses to administer moderate sedation for ASA I–II patients under physician supervision. ASA III+ requires documented anaesthetic review before sedation.
All GCC regulatory bodies require nurses to practise sedation within documented protocols, with physician oversight and emergency equipment immediately available.
Always document baseline observations before any sedative drug is given. Post-sedation changes cannot be interpreted without a baseline.
Facial abnormalities, trauma, obesity, short neck, large tongue, micrognathia, macroglossia, beard
Mouth opening ≥3 fingers, hyoid-chin distance ≥3 fingers, hyoid-thyroid cartilage ≥2 fingers
Class I: soft palate, fauces, uvula visible. Class II: uvula partially visible. Class III: only base of uvula. Class IV: soft palate not visible. Class III-IV = difficult airway risk.
Epiglottitis, peritonsillar abscess, neck mass, stridor — any obstruction precludes nurse-led sedation
Cervical spine injury, rheumatoid arthritis, ankylosing spondylitis, cervical fusion — reduced extension impairs bag-mask ventilation and intubation
Any Mallampati III/IV, neck immobility, obesity (BMI >35), OSA, previous failed intubation — anaesthetic presence required
Patients fasting for Ramadan are NPO from Fajr to Maghrib — technically meeting solid food fasting requirements. However: still confirm last clear fluid timing (Suhoor fluids count). Do not assume adequate fasting without explicit assessment. Ramadan fasting does not replace formal pre-sedation fasting documentation.
Sedation consent must be obtained separately from procedure consent. The patient must understand:
GCC Practice: Many facilities require a separate sedation consent form signed before the procedure. Check local facility policy — DHA and DOH both require documented patient agreement for sedation as a distinct intervention.
Do not proceed with nurse-administered sedation if any high-risk feature is present without documented anaesthetic review and approval.
| Drug | Class | Usual IV Dose | Onset | Duration | Key Notes |
|---|---|---|---|---|---|
| Midazolam | Benzodiazepine | 1–2.5 mg IV, titrate in 0.5–1 mg increments | 2–3 min | 30–60 min | Halve dose if combined with opioid. Reduce in elderly (start 0.5–1 mg). |
| Fentanyl | Opioid | 25–50 mcg IV, titrate q2–3min | 1–2 min | 30–60 min | Respiratory depression risk — have naloxone ready. Short-acting. |
| Propofol | IV anaesthetic | 0.5–1 mg/kg slow IV (induces deep sedation) | <1 min | 5–10 min | Anaesthetist/trained provider ONLY. Rapid onset, apnoea risk, hypotension. |
| Ketamine | Dissociative | 1–2 mg/kg IV or 4–6 mg/kg IM | 30–60 sec IV | 10–20 min IV | Bronchodilator — useful in asthma. Watch for emergence reactions. Copious secretions. |
| Dexmedetomidine | Alpha-2 agonist | Loading 1 mcg/kg over 10 min, then 0.2–0.7 mcg/kg/hr | 15–30 min | Infusion | ICU sedation (RASS -2 to 0). Minimal respiratory depression. Bradycardia risk. |
| Nitrous Oxide (Entonox) | Inhaled analgesic/sedative | 50:50 N2O/O2 — patient self-administers via mouthpiece | 30–60 sec | 2–5 min | Rapid onset and offset. Only moderate sedation achievable. Contraindicated: pneumothorax, bowel obstruction, B12 deficiency. |
Re-sedation risk: Flumazenil wears off before midazolam. Monitor for 2 hours after reversal. Do NOT use in chronic benzodiazepine users — precipitates seizures.
Re-narcotization: Fentanyl may outlast naloxone. Observe 2 hours minimum after reversal. Infusion may be needed for long-acting opioids.
Combination synergy: When midazolam and fentanyl are used together, respiratory depression risk multiplies — NOT just additive. Standard protocol: HALVE the midazolam dose when co-administering with any opioid.
Patient: 70 kg, ASA II, fentanyl + midazolam combination.
Ketamine produces a dissociative state — patients may appear awake but are unresponsive. Unique properties make it useful in specific GCC contexts:
Contraindications: Raised ICP, uncontrolled hypertension, thyroid storm, schizophrenia. Use with caution in cardiovascular disease.
Entonox is self-administered via a demand valve — the patient cannot over-sedate themselves (hand drops, releasing mask). Widely used in GCC for:
Continuous pulse oximetry throughout. Alarm threshold: SpO2 <94%. Target SpO2 ≥95% during sedation.
Gold standard. Detects apnoea before SpO2 drops. GCC standard for ALL moderate+ sedation. Normal ETCO2: 35–45 mmHg.
Every 5 minutes minimum. Alert if systolic drops >20% from baseline or falls below 90 mmHg.
Continuous 3-lead monitoring. Particularly important for cardiac patients, elderly, and those receiving ketamine or dexmedetomidine.
Clinical assessment q5min. Alert if RR <8 or >25 breaths/min. Capnography supplements clinical RR counting.
RASS score q5min. Stimulate patient to assess purposeful response. Loss of purposeful response = deepening beyond target — act immediately.
Why capnography beats pulse oximetry for apnoea detection: SpO2 drops 1–3 minutes AFTER apnoea begins (the oxygen reserve effect). ETCO2 flatlines within 15–30 seconds of apnoea — giving much earlier warning. This is why GCC capnography for all moderate sedation is a regulatory expectation, not just best practice.
The monitoring nurse must have: current BLS/ACLS certification, familiarity with sedation reversal protocols, and competency in airway management (OPA/NPA, bag-mask ventilation).
Medicolegal importance: GCC regulatory bodies (DHA, DOH, SCFHS) require complete contemporaneous sedation records. Incomplete documentation is treated as an incident.
Stimulate patient. If unresponsive: consider naloxone if fentanyl given, or flumazenil if midazolam given. Do not wait for SpO2 to fall before acting — treat bradypnoea as pre-arrest respiratory depression.
Stop sedation titration. Fluid bolus (250–500 mL 0.9% NaCl if not contraindicated). Reposition (legs elevated). Notify physician. Vasopressors if unresponsive to fluids and sepsis/shock suspected. Check ECG.
RASS -3 or below means the patient has entered deep sedation — beyond the nurse-administered moderate sedation target. Call for anaesthetic assistance immediately. Maintain airway, supplemental O2, prepare bag-mask. Do not give further sedation.
2–4 L/min via nasal cannula throughout procedure. Adjust to maintain SpO2 ≥95%.
Increase to 10–15 L/min via simple face mask or non-rebreather. Reposition airway first.
Bag-valve-mask, OPA and NPA (sized), suction, oxygen source confirmed, reversal agents drawn up.
Signs: snoring, stridor, paradoxical chest movement, SpO2 falling, ETCO2 flat or erratic, patient not ventilating despite chest movement attempts.
RR <8, SpO2 falling, ETCO2 rising (hypoventilation) or absent (apnoea), shallow breathing, cyanosis.
Propofol infusion syndrome: Rare but life-threatening — metabolic acidosis, cardiac failure, rhabdomyolysis with high-dose prolonged propofol infusion in ICU. Stop propofol immediately if suspected.
Incidence: 1–2% — more common in elderly, children, those with chronic benzodiazepine use or anxiety disorders. Patient becomes agitated, disinhibited, aggressive, crying rather than sedated.
The modified Aldrete score is used to assess readiness for discharge from the recovery area. Score each parameter 0, 1, or 2. Discharge requires a score of 9 or more out of 10.
| Parameter | Score 0 | Score 1 | Score 2 |
|---|---|---|---|
| Activity (limb movement) | No limbs move voluntarily | 2 limbs move | 4 limbs move |
| Respiration | Apnoeic | Limited effort | Breathes deeply, coughs freely |
| Circulation (BP vs pre-op) | >50 mmHg difference | 20–50 mmHg difference | <20 mmHg difference |
| Consciousness | Not responding | Arousable to stimulation | Fully awake |
| SpO2 | <90% on O2 | Requires supplemental O2 | >92% on room air |
Clinical note: Even if Aldrete ≥9, patients must not be discharged until they have taken oral fluids without nausea, are independently mobile (or at their pre-procedure baseline), and have been assessed for pain.
GCC Legal Requirement: Escort documentation is a medico-legal requirement across DHA, DOH, and SCFHS jurisdictions. If no responsible adult escort, the patient must not be discharged — facility must make alternative arrangements.
| Level | Responsiveness | Airway | Ventilation | CV Function |
|---|---|---|---|---|
| Minimal | Normal to verbal | Unaffected | Unaffected | Unaffected |
| Moderate | Purposeful to verbal/touch | Maintained independently | Adequate | Usually maintained |
| Deep | Purposeful to pain only | May require intervention | May be inadequate | Usually maintained |
| GA | Not arousable | Intervention required | Often impaired | May be impaired |
Exam tip: RASS is assessed first verbally, then by movement. If no response to voice, assess response to physical stimulus. Document the most awake observation.
Ramadan exam question: A patient observing Ramadan fast presents for a procedure. Are they adequately fasted? Answer: Not automatically. Must confirm time of Suhoor (last fluid intake) and calculate hours elapsed. Standard fasting rules still apply.
| Drug | Typical Sedation Dose | Reversal Agent | Reversal Dose | Key Exam Point |
|---|---|---|---|---|
| Midazolam | 1–2.5 mg IV titrated (halve with opioid) | Flumazenil | 200 mcg IV, repeat 100 mcg q60 sec, max 1 mg | Re-sedation risk — flumazenil duration < midazolam |
| Fentanyl | 25–50 mcg IV (25 mcg increments) | Naloxone | 400 mcg IV/IM; or titrate 100–200 mcg IV | Re-narcotization — naloxone wears off first |
| Propofol | 0.5–1 mg/kg (deep sedation — anaesthetist only) | None | No pharmacological reversal available | Nurse does NOT administer propofol for sedation in GCC |
| Ketamine | 1–2 mg/kg IV or 4–6 mg/kg IM | None | No reversal — supportive care | Bronchodilator — preferred in asthma. Emergence reactions. |
Answer: In moderate sedation the patient responds purposefully to verbal commands or light touch, maintains their own airway, and breathes spontaneously. In deep sedation, purposeful response requires painful stimulation, airway support may be needed, and spontaneous ventilation may be inadequate. The key word is "purposeful response."
Answer: Stimulate the patient (call name, sternal rub), reposition airway (head tilt/chin lift or jaw thrust), apply supplemental oxygen. If no response, initiate bag-mask ventilation and administer naloxone 400 mcg IV/IM (opioid reversal first, as fentanyl is the more likely cause of apnoea), then flumazenil 200 mcg if insufficient response. Call for anaesthetic assistance.
Answer: Pulse oximetry detects a fall in blood oxygen saturation, but this occurs 1–3 minutes after ventilation has stopped (because of the oxygen reservoir in the lungs and blood). Capnography (ETCO2) detects cessation of exhaled CO2 within 15–30 seconds of apnoea — giving an earlier, actionable warning. This is why capnography is the gold standard monitoring for moderate sedation.
Answer: This is a paradoxical reaction to midazolam — more common in elderly patients and those with underlying anxiety or chronic benzodiazepine use. Management: do NOT give more midazolam. Give flumazenil 200 mcg IV to reverse the benzodiazepine, reduce stimulation, calm the patient. Document and flag for future — avoid benzodiazepines in subsequent sedation for this patient.
Answer: Procedural sedation target is RASS 0 to -2 (alert/calm to light sedation — brief eye opening to voice). RASS -5 is unarousable — no response to voice or physical stimulation. This is equivalent to general anaesthesia territory and requires immediate anaesthetic support and airway management.
Answer: Ketamine is the preferred agent because it is a bronchodilator — it stimulates catecholamine release which causes bronchodilation. It also maintains cardiovascular stability and preserves airway reflexes better than benzodiazepines or propofol. Note: midazolam pre-medication reduces emergence reactions; atropine reduces secretions. Propofol also has some bronchodilatory properties but requires anaesthetic administration.
Answer: The modified Aldrete score assesses 5 parameters — activity, respiration, circulation, consciousness, and SpO2 — each scored 0, 1, or 2 (maximum 10). A score of 9 or above is required for discharge from the recovery area. However, the patient must also have a responsible adult escort, be able to tolerate oral fluids, and have received written discharge instructions covering the 24-hour post-sedation restrictions.